Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung Cancer

INTRODUCTION: Health technology assessment is not required for regulatory submission or approval in either the United States (US) or Japan. This study was designed as a cross-country evaluation of cost analyses conducted in the US and Japan based on the PRONOUNCE phase III lung cancer trial, which c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, Lisa M., Rajan, Narayan, Winfree, Katherine, Davey, Peter, Ball, Mark, Knox, Hediyyih, Graham, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679782/
https://www.ncbi.nlm.nih.gov/pubmed/26650816
http://dx.doi.org/10.1007/s12325-015-0270-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679782/
https://www.ncbi.nlm.nih.gov/pubmed/26650816
http://dx.doi.org/10.1007/s12325-015-0270-9

Ejemplares similares